Drug shortage
Valsartan Tablet · Mylan Pharmaceuticals Inc., a Viatris Company
FDA drug shortage · To Be Discontinued · updated Nov 19, 2025
Key facts
| Generic name | Valsartan Tablet |
|---|---|
| Company | Mylan Pharmaceuticals Inc., a Viatris Company |
| Presentation | Valsartan, Tablet, 40 mg (NDC 0378-5807-93) |
| Dosage form | Tablet |
| Status | To Be Discontinued |
| Therapeutic category | Cardiovascular |
| Package NDCs | 0378-5807-93 |
| First posted | Nov 19, 2025 |
| Last updated | Nov 19, 2025 |
| Discontinued | Nov 19, 2025 |
At a glance
- 1–9 Package NDCs affected
- 1–9 FDA shortage records for this drug
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug shortages
The FDA Drug Shortages Database lists current and resolved shortages of drugs, with presentations, affected NDCs and reasons reported by manufacturers.
Source: U.S. Food and Drug Administration (FDA), Drug Shortages Database · Source date: